Josh Walsh

Josh Walsh, Founder and CEO of BranchLab, discusses the evolution of pharmaceutical advertising with a focus on innovative data usage. He explains how BranchLab employs neural networks trained on non-health data to uphold privacy while providing audience insights. Walsh shares insights on strategic funding from Lance Armstrong’s Next Ventures and examines the implications of Deep Intent’s substantial acquisition. The conversation also highlights ongoing regulatory shifts and how responsible advertising could positively impact public health.